Literature DB >> 22518257

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation: risk-benefit ratio remains highly favorable.

Alberto Maud1, Kamakshi Lakshminarayan, Adnan I Qureshi.   

Abstract

Entities:  

Year:  2010        PMID： 22518257      PMCID： PMC3317288     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN： 1941-5893


× No keyword cloud information.
  7 in total

Review 1.  10 questions on atrial fibrillation.

Authors:  Alberto Maud; David C Anderson
Journal:  Neurologist       Date:  2008-11       Impact factor: 1.398

2.  A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).

Authors:  Amar Rash; Tom Downes; Robin Portner; Wilf W Yeo; Nicolette Morgan; Kevin S Channer
Journal:  Age Ageing       Date:  2006-12-15       Impact factor: 10.668

3.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

4.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

5.  Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

Authors:  Carl van Walraven; Robert G Hart; Stuart Connolly; Peter C Austin; Jonathan Mant; F D Richard Hobbs; Peter J Koudstaal; Palle Petersen; Francisco Perez-Gomez; J Andre Knottnerus; Beppie Boode; Michael D Ezekowitz; Daniel E Singer
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

6.  Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation.

Authors:  Elaine M Hylek; James D'Antonio; Carmella Evans-Molina; Carol Shea; Lori E Henault; Susan Regan
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

7.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors:  Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321
  7 in total
  1 in total

Review 1.  Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation.

Authors:  Shilpa D Kailas; Sirisha Reddy Thambuluru
Journal:  Cureus       Date:  2016-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.